Live Chat on The Biotech Forum has been dominated by discussion of covered call opportunities in recent quarters. To see what I and the other season biotech investors are targeting as trading ideas in real-time, just initiate your free trial into The Biotech Forum by clicking HERE .When I last looked at Apellis Pharmaceuticals, Inc. ( NASDAQ: APLS ) in early March of this year, I concluded that article by stating the picture was a bit of a 'mixed bag'. However, the stock merited aBret leads the investing gr ...